Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

925.265
-8.623-0.92%
Number of Gainers:2
Number of Losers:15
Number of Flat:- -
PE:- -
High:930.611
Open:930.611
Low:904.457
Close:933.888
Volume:536.53M
Turnover:4.82B
Market Cap:620.70B
Float Cap:517.91B

Loading ...

Sino Biopharmaceutical H1 Revenue RMB 1,944 Million

THOMSON REUTERS
·
Aug 19

Sino Biopharmaceutical - Interim Dividend of Hk7 CENTS\nPER Share

THOMSON REUTERS
·
Aug 19

BYD Electronic (International) Stock Sheds 2.0% in Hong Kong

Dow Jones
·
Aug 19

This Sector Is Experiencing a Major Surge

Deep News
·
Aug 19

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.
·
Aug 19

Switzerland's DocMorris H1 Revenue Rises on RX Growth, Raises 2026 Outlook

Reuters
·
Aug 19

Sweden's Ambea Q2 Sales Beat Estimates on Higher Occupancy

Reuters
·
Aug 19

Press Release: Ping an Good Doctor Announces 2026 Interim Results

Dow Jones
·
Aug 19

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

Reuters
·
Aug 18

New Push to Boost Spending Targets County-Level Markets: What's Behind the Shift?

Deep News
·
Aug 18

Ping An Healthcare's First-Half Results Released: Corporate Wellness Segment Shows Steady Growth, AI Full-Process Support Boosts High-Quality Development

Stock News
·
Aug 18

Prenetics Global Q2 Revenue Jumps on AI Brand Growth

Reuters
·
Aug 18

Ping an Healthcare Names Yougang Zhu Chairman in Board Reshuffle

Reuters
·
Aug 18

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 18

Sinopharm Appoints Yang Binghua to Board Strategy and Investment Committee

Reuters
·
Aug 18

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

Reuters
·
Aug 18

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS
·
Aug 18

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS
·
Aug 18

China's Ping an Healthcare H1 Revenue Profit Jumps on Corporate Client Base Expansion

Reuters
·
Aug 18

China Traditional Chinese Medicine Holdings Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 18